
Pfizer Stock Rout Creates Opportunity for Income Investors as Pipeline Recovery Looms
Pfizer stock down 50% from 2021 peaks due to patent losses and GLP-1 weakness, but 6.5% dividend yield and promising pipeline may attract long-term investors.
PFEdividend yieldGLP-1 drugs